To investigate the effects of amlodipine besylate tablets combined with anti-tuberculosis drugs on clinical symptoms and blood pressure level in patients with pulmonary tuberculosis complicated with hypertension.
A total of 152 patients with pulmonary tuberculosis combined with hypertension admitted to our hospital from March 2021 to March 2024 were enrolled. The patients were divided into the control group and the observation group by simple sorting random method, with 76 cases in each group. On the basis of conventional quadruple anti-tuberculosis treatment, the control group was treated with nifedipine extended-release tablets, and the observation group was treated with amlodipine besylate tablets, both groups continued treatment for 2 months. Blood pressure, vascular endothelial cell factors, and renal function indexes were compared between the two groups before and after treatment. Improvement of patients' clinical symptoms, degree of lesion absorption were evaluated. The blood pressure compliance and blood pressure reduction were analyzed in patients with different grades of hypertension and degrees of pulmonary tuberculosis.
The effective rates of clinical symptom improvement in the observation group was higher than that in the control group(80.26% vs. 92.11%, P<0.05). After treatment, the systolic and diastolic blood pressure in both groups decreased day and night compared to before treatment, and the observation group was lower than the control group(P<0.05). Blood vessel endothelial cytokines such as nitric oxide, thrombomodulin, and endothelin, as well as renal function indicators including creatinine and urea nitrogen, all improved compared to before treatment, and the observation group was better than the control group(P<0.05). The proportion of lesions with absorption grades 1 and 2 in the observation group were higher than those in the control group, while the proportions of grades 3 and 4 were lower(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(13.16% vs. 89%, P > 0.05). In the grade 2 hypertension subgroup and the severe pulmonary tuberculosis subgroup, the blood pressure control rate in the observation group was higher than that in the control group, and the reductions in both systolic and diastolic blood pressure were greater than those in the control group(P<0.05).
Short-term treatment with amlodipine besylate tablets combined with anti-tuberculosis drugs can effectively control blood pressure levels in patients with pulmonary tuberculosis complicated with hypertension, improve the clinical symptoms, regulate the levels of vascular endothelial cytokines, with mild impairment to renal function, and has good safety. Particularly in the grade 2 hypertension subgroup and the severe pulmonary tuberculosis subgroup, the blood pressure control rate is higher and the blood pressure reduction is more significant, making it worthy of clinical application.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |